Dr. Megan Kalambo is a breast imaging radiologist at The University of Texas MD Anderson Cancer Center (MDACC) and Clinical Medical...

Holds a Master degree in biochemistry from the Univerté du Québec à Montréal and is responsible for the clinical research operations. He...

SurgMark GmbH today announced that the U.S. Food & Drug Administration (FDA) has issued a 510(k) premarket notification for its...

Biomaterial in breast cancer diagnostics: Hamburg-based start-up SurgMark presents SchurSign® Tissue Marker at MEDICA/COPAMED 2023...